Stocks making the biggest moves midday: MongoDB, Boeing, Kodiak Sciences, Roblox, Nvidia & more

MongoDB sank about 18% after CEO CJ Desai left to join Meta, while Boeing fell 5% on a disclosed 737 Max software glitch and Roblox declined 6% following a Jefferies downgrade. AI-linked infrastructure names sold off after OpenAI paused training of its newest models, with Lumentum and Coherent down more than 5%, while Meta slipped nearly 4%; Nvidia bucked the trend, rising 2% after unveiling AI safety software and increasing its buyback authorization by $150 billion. Higher yields, with the 10-year Treasury above 5.2%, pressured gold and Newmont, while oil near $93 per barrel supported Exxon and Chevron but weighed on airlines; Kodiak Sciences surged about 170% on positive Phase 3 eye-treatment results.

Analysis

MongoDB’s selloff is less about a one-quarter operating disruption than a renewed governance discount at a point when its consumption-growth recovery must be executed cleanly. The interim appointment reduces immediate succession uncertainty, but the market will likely demand evidence in the next two earnings cycles that Atlas net revenue retention and large-enterprise workload wins are intact; absent that, a leadership event can become the rationale for further multiple compression. Meta’s senior enterprise-platform hire is also a modest read-through that hyperscalers are still competing aggressively for software talent, raising retention-cost risk across cloud-data vendors rather than creating a direct Meta revenue catalyst.

The AI complex is bifurcating: companies whose valuation depends on a near-term incremental buildout cycle—LITE, COHR, GLW, MRVL and, to a lesser extent, MU—are vulnerable if model-training pauses translate into delayed capacity orders. NVDA’s relative strength is more defensible because capital return creates a buyer with little dependence on incremental external demand, but it does not eliminate the risk that reduced training intensity eventually lowers accelerator utilization and supplier orders. The key 1-3 month falsifier is hyperscaler capex guidance and lead-time commentary, not a single agent-safety headline; a sustained cut in optical/datacenter order visibility would disproportionately pressure the lower-quality, higher-operating-leverage names.

Higher crude and yields create a cleaner cross-asset margin trade than the isolated equity moves suggest. Airlines have limited ability to reprice booked capacity immediately, so jet-fuel inflation should hit near-term unit-cost guidance before fare increases can offset it; refiners could be a more nuanced beneficiary than XOM/CVX if crack spreads remain firm. Conversely, the yield move is a real valuation headwind for long-duration software and gold, while the Boeing software disclosure is principally a certification and delivery-timing risk: even without broad fleet remediation, another regulatory review could impair cash conversion through 2026.

Kodiak’s binary repricing should not be treated as a durable fundamental rerating until durability, safety, dosing frequency, and commercial positioning versus EYLEA/VEGF alternatives are disclosed. The apparent cybersecurity bid is also not yet an earnings catalyst: publicly available-data use does not establish incremental security spend, so PANW/CRWD should be owned only on verified billings and remaining-performance-obligation acceleration rather than narrative beta.

Key Decisions for Investors

• Initiate a 1-3 month pair: long NVDA / short a basket of LITE and COHR. NVDA’s buyback provides downside absorption, while optical names carry greater sensitivity to deferred AI-cluster deployments; target 10-15% relative outperformance. Exit if hyperscaler capex guidance accelerates or optical order books show no pushouts.
• Maintain an opportunistic short/underweight MDB through the next earnings report rather than chase the initial gap lower. Cover if Atlas growth, net revenue retention, and operating-margin guidance are reaffirmed without customer churn; the thesis is invalidated by operating continuity, not merely a permanent CEO appointment.
• Express the energy-cost squeeze via long XOM or CVX versus short DAL and UAL over the next 4-8 weeks, sized modestly given oil volatility. The trade works if crude remains above roughly $90/bbl and airline fuel-cost guidance rises; stop out if crude falls below $85/bbl or airlines demonstrate fare recapture materially above fuel inflation.
• Avoid chasing KOD after the event-driven move; place a watch alert for trial-detail disclosure and financing plans. Consider only a defined-risk position after durability and safety data establish differentiation, because post-Phase-3 commercialization, manufacturing, and dilution risk can overwhelm the clinical signal.
• Stay underweight BA pending evidence that certification and delivery cadence are unaffected. A favorable regulatory determination and stable free-cash-flow/delivery guidance would falsify the short-bias; absent that, delivery-delay risk has greater valuation relevance than the immediate software fix.